These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33460063)

  • 1. High infiltration of CD20
    Chen MM; Zeng GP; Li J; Fu JH; Long YY; Pan JY; Wei LZ; Guan JY; Lin YX; You H; Si C; Li WX; Liang YJ; Liu DH; Liu F; Liu F
    Br J Haematol; 2020 Dec; 191(5):e116-e120. PubMed ID: 33460063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
    Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
    J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
    Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
    Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.
    Wang L; Wang Z; Xia ZJ; Lu Y; Huang HQ; Zhang YJ
    Tumour Biol; 2015 Sep; 36(10):7717-23. PubMed ID: 25935537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis.
    Kim WY; Jung HY; Nam SJ; Kim TM; Heo DS; Kim CW; Jeon YK
    Virchows Arch; 2016 Nov; 469(5):581-590. PubMed ID: 27595782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High IL-6 expression in the tumor microenvironment is associated with poor prognosis of patients with extranodal natural / killer T-cell lymphoma (ENKTL).
    Rong Q; Gao Y; Cai Q; Wang X; Bai B; Ping L; He H; Rao H; Zhang Y; Li Z; Cai Q; Jiang W; Huang H
    Expert Rev Anticancer Ther; 2021 Jan; 21(1):121-127. PubMed ID: 33397158
    [No Abstract]   [Full Text] [Related]  

  • 7. The Prognostic Importance of CD20
    Edin S; Kaprio T; Hagström J; Larsson P; Mustonen H; Böckelman C; Strigård K; Gunnarsson U; Haglund C; Palmqvist R
    Sci Rep; 2019 Dec; 9(1):19997. PubMed ID: 31882709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NK/T-cell lymphoma, nasal type: a retrospective study in China.
    Huang X; Sun Q; Fu H; Zhou X; Guan X; Wang J
    Pathol Res Pract; 2014 Jun; 210(6):351-6. PubMed ID: 24642368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological analysis of immunohistochemical CD47 and signal-regulatory protein-α expression in Extranodal Natural killer/T-cell lymphoma.
    Tan Z; Zhang Q; Wang Y; Wang Y; Zhang S; Xing X; Liu H; Shen Z; Sang W
    Ann Hematol; 2024 Aug; 103(8):3033-3042. PubMed ID: 38886192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of TIM-3 and LAG-3 in extranodal NK/T cell lymphoma, nasal type.
    Feng Y; Zhong M; Liu Y; Wang L; Tang Y
    Histol Histopathol; 2018 Mar; 33(3):307-315. PubMed ID: 28901003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extranodal NK/T-cell lymphoma in Tunisia: clinicopathological features, immunophenotype and EBV infection.
    Missaoui N; Mestiri S; Bouriga A; Abdessayed N; Belakhdher M; Ghammem M; Abdelkefi M; Mokni M; Hmissa S
    J Egypt Natl Canc Inst; 2019 Oct; 31(1):1. PubMed ID: 32372136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of PDGFRA and CMYC in extranodal NK/T-cell lymphoma and their prognostic implications].
    Chen YP; Zhu WF; Lin JY; He TM; Ma HM; Lu JP; Ye XA; Xu CW; Chen G
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):825-830. PubMed ID: 28056296
    [No Abstract]   [Full Text] [Related]  

  • 13. Aberrant differential expression of EZH2 and H3K27me3 in extranodal NK/T-cell lymphoma, nasal type, is associated with disease progression and prognosis.
    Liu J; Liang L; Huang S; Nong L; Li D; Zhang B; Li T
    Hum Pathol; 2019 Jan; 83():166-176. PubMed ID: 30218753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma.
    Shi JY; Gao Q; Wang ZC; Zhou J; Wang XY; Min ZH; Shi YH; Shi GM; Ding ZB; Ke AW; Dai Z; Qiu SJ; Song K; Fan J
    Clin Cancer Res; 2013 Nov; 19(21):5994-6005. PubMed ID: 24056784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary breast CD20-positive extranodal NK/T cell lymphoma with stomach involvement: a case report and literature review.
    Zhang Y; Wang K; Tan Q; Yang K; Wu D; Xu Y; Zhao X; Jiang Z
    Diagn Pathol; 2021 Nov; 16(1):103. PubMed ID: 34749754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome.
    Arias-Pulido H; Cimino-Mathews A; Chaher N; Qualls C; Joste N; Colpaert C; Marotti JD; Foisey M; Prossnitz ER; Emens LA; Fiering S
    Breast Cancer Res Treat; 2018 Sep; 171(2):273-282. PubMed ID: 29858752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic features and survival outcomes of CD30 expression in extranodal natural killer/T-cell lymphoma.
    Shen Z; Wang Y; Xie R; Zhang Q; Xing X; Zhang S; Liu H; Sang W
    Am J Clin Pathol; 2024 Jul; 162(1):95-102. PubMed ID: 38387041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extranodal natural killer/T-Cell lymphoma: A population-based comparison of sinonasal and extranasal disease.
    Vazquez A; Khan MN; Blake DM; Sanghvi S; Baredes S; Eloy JA
    Laryngoscope; 2014 Apr; 124(4):888-95. PubMed ID: 24114591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary central nervous system extranodal nasal-type natural killer/T-cell lymphoma with CD20 expression.
    Li D; Fu F; Lian L
    Neuropathology; 2018 Apr; 38(2):198-204. PubMed ID: 29063643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma.
    Yhim HY; Kim JS; Mun YC; Moon JH; Chae YS; Park Y; Jo JC; Kim SJ; Yoon DH; Cheong JW; Kwak JY; Lee JJ; Kim WS; Suh C; Yang DH;
    Biol Blood Marrow Transplant; 2015 Sep; 21(9):1597-604. PubMed ID: 25963920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.